Guest Contributors
 Simon Fredriksson, CEO and Co-founder of Pixelgen Technologies |
 Paul Freemont, Co-director of UK Innovation and Knowledge Centre for Synthetic Biology at Imperial College |
 Director, University of Illinois, Research Park |
 Co-Founder, Co-CEO, Emerald Therapeutics |
 Columnist, Bio-IT World |
 Mark Gardner, CEO of Omniseq |
 Director, Research Programs and Operations, Amyris Inc. |
 Sylvain Gariel, COO of DNA Script |
 Russell Garlick, CSO of SeraCare |
 Sean George, CEO of Invitae |
 Researcher, Fred Hutchinson Cancer Center; CEO, Scisco Genetics |
 President, The Linus Group |
 John Gill, Senior Director of Research and Innovation at Telesis |
 Director, Duke Center for Applied Genomics and Precision Medicine |
 VP of Communications, CLC Bio |
 Kirstin Goldring, Principal Scientist at Astra Zeneca, Counselor at the European Society for Biopreservation and Biobanking, Member of ISBER or the International Society for Biorepositories |
 Brett Goldsmith, Chief Technology Officer at Cardea |
 Professor, UCSD |
 Partner, VenBio |
 |
 Carla Grandori , CEO and Founder of SEngine |
 Professor, University of Houston |
 Brad Gray, CEO of NanoString |
 John Greally |
 Professor of Law, Stanford |
